Ravi Salgia

发表

Opportunities for improving cancer treatment using systems biology.

Jeffrey T. Chang, Andrea Bild, Adam L. Cohen, 2019, Current opinion in systems biology.

The DNA walk and its demonstration of deterministic chaos—relevance to genomic alterations in lung cancer

Haiqing Li, Ravi Salgia, Blake Hewelt, 2019, Bioinform..

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database

Eneida A. Mendonça, Ravi Salgia, Rifat Hasina, 2011, Journal of Clinical Bioinformatics.

Appendix – Diagnostic Algorithms

Ravi Salgia, Isa Mambetsariev, Thomas A. Hensing, 2018 .

Vascular Endothelial Growth Factor-induced Migration of Multiple Myeloma Cells Is Associated with β1 Integrin- and Phosphatidylinositol 3-Kinase-dependent PKCα Activation*

Kenneth C. Anderson, Ravi Salgia, Takashi Kijima, 2002, The Journal of Biological Chemistry.

Molecular biomarkers for future screening of lung cancer

Ravi Salgia, R. Salgia, T. Hensing, 2013, Journal of surgical oncology.

MET and phosphorylated MET as potential biomarkers in lung cancer.

Ravi Salgia, Theodore Karrison, Maria Tretiakova, 2011, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Heber MacMahon, John K Field, Shaf Keshavjee, 2012, The Journal of thoracic and cardiovascular surgery.

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation

Heber MacMahon, Ravi Salgia, Everett E. Vokes, 2016, Oncotarget.

Characterization of NOL7 Gene Point Mutations, Promoter Methylation, and Protein Expression in Cervical Cancer

Alexander Langerman, Ravi Salgia, Timothy Best, 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors

Ravi Salgia, R. Salgia, J. Griffin, 1997, Oncogene.

Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.

Ravi Salgia, Takashi Kijima, Gautam Maulik, 2002, Cancer research.

Value-Based Medicine and Integration of Tumor Biology.

Ravi Salgia, Isa Mambetsariev, Gabriel A Brooks, 2017, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes

Kevin P. White, Christopher D. Brown, Damian Rieke, 2014, Clinical Cancer Research.

Geographic Variation in Radiologist Capacity and Widespread Implementation of Lung Cancer CT Screening

Heber MacMahon, Ya-Chen Tina Shih, Ravi Salgia, 2014, Journal of medical screening.

MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance.

Ravi Salgia, Rajani Kanteti, R. Salgia, 2009, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma

Ravi Salgia, Hedy L. Kindler, Rajani Kanteti, 2016, Scientific Reports.

MET molecular mechanisms and therapies in lung cancer

Ravi Salgia, R. Salgia, Ryan E Lawrence, 2010, Cell adhesion & migration.

CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases

Ravi Salgia, Rifat Hasina, Kenan Onel, 2010, PloS one.

The role of ephrins and Eph receptors in cancer.

Ravi Salgia, R. Salgia, P. Ma, 2004, Cytokine & growth factor reviews.

Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma

Ravi Salgia, Nicholas Campbell, Sonali M. Smith, 2012, Targeted Oncology.

Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer.

Soma Das, Federico Innocenti, Michael L Maitland, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer

Ravi Salgia, R. Salgia, Neelu Puri, 2008, Journal of carcinogenesis.

Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.

Mark Rosenzweig, Joel Greshock, Doron Lipson, 2015, Cancer discovery.

MET in the Driver's Seat: Exon 14 Skipping Mutations as Actionable Targets in Lung Cancer.

Ravi Salgia, R. Salgia, M. Sattler, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation.

Ravi Salgia, Takashi Kijima, R. Salgia, 2002, The Journal of biological chemistry.

Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.

Ravi Salgia, Kitt Shaffer, Benjamin L Ebert, 2003, The oncologist.

Molecular pathways and therapeutic targets in lung cancer

Ravi Salgia, Raphael Bueno, R. Bueno, 2014, Oncotarget.

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

Ravi Salgia, Edward A Fox, Erik Schaefer, 2005, Cancer research.

Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.

Ravi Salgia, R. Salgia, P. Ma, 2007, Mass spectrometry reviews.

A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.

Ravi Salgia, Andrey Khramtsov, R. Salgia, 2007, Cancer research.